February 8, 2025 · Form 4 insider transaction
ROBERTS EIRY bought 1,860 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.